Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A OTT

Showing results (531-540 of 667) with videos related to

Pageof 67
Sort By:
The Annals of Thoracic Surgery|July 26, 2005
Concomitant brachiocephalic and coronary artery disease: outcome and decision analysisThomas J Takach, George J Reul, J Michael Duncan, et al.
Cancer Immunology Research|March 2, 2017
Comprehensive Meta-analysis of Key Immune-Related Adverse Events from CTLA-4 and PD-1/PD-L1 Inhibitors in Cancer PatientsGuillermo De Velasco, Youjin Je, Dominick Bossé, et al.
Burns : Journal of the International Society for Burn Injuries|February 5, 2008
Prevention of Staphylococcus aureus burn wound colonization by nasal mupirocinA M D Kooistra-Smid, E van Zanten, A Ott, et al.
Journal of Clinical Immunology|May 28, 2004
T cells recognize multiple GAD65 and proinsulin epitopes in human type 1 diabetes, suggesting determinant spreadingPatrick A Ott, Marcus T Dittrich, Bernhard A Herzog, et al.
Frontiers in Oncology|April 16, 2019
Palliative Radiation Therapy for Vertebral Metastases and Metastatic Cord Compression in Patients Treated With Anti-PD-1 TherapyMuhammad Mohsin Fareed, Luke R G Pike, Andrew Bang, et al.
Molecular Pharmaceutics|November 4, 2014
In silico prediction of pharmaceutical degradation pathways: a benchmarking studyMark H Kleinman, Steven W Baertschi, Karen M Alsante, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 25, 2019
Developing real-world comparators for clinical trials in chemotherapy-refractory patients with gastric cancer or gastroesophageal junction cancerIan Chau, Dung T Le, Patrick A Ott, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|November 4, 2019
Correction to: Developing real-world comparators for clinical trials in chemotherapy-refractory patients with gastric cancer or gastroesophageal junction cancerIan Chau, Dung T Le, Patrick A Ott, et al.
Cancer Immunology, Immunotherapy : CII|February 13, 2024
INDUCE-2: A Phase I/II, open-label, two-part study of feladilimab in combination with tremelimumab in patients with advanced solid tumorsJohn F Hilton, Patrick A Ott, Aaron R Hansen, et al.
Journal of Autoimmunity|July 9, 2004
Increased in vivo frequency of IA-2 peptide-reactive IFNgamma+/IL-4- T cells in type 1 diabetic subjectsBernhard A Herzog, Patrick A Ott, Marcus T Dittrich, et al.
Pageof 67

Showing results (531-540 of 667) with videos related to

Sort By:
Pageof 67
The Annals of Thoracic Surgery|July 26, 2005
Concomitant brachiocephalic and coronary artery disease: outcome and decision analysisThomas J Takach, George J Reul, J Michael Duncan, et al.
Cancer Immunology Research|March 2, 2017
Comprehensive Meta-analysis of Key Immune-Related Adverse Events from CTLA-4 and PD-1/PD-L1 Inhibitors in Cancer PatientsGuillermo De Velasco, Youjin Je, Dominick Bossé, et al.
Burns : Journal of the International Society for Burn Injuries|February 5, 2008
Prevention of Staphylococcus aureus burn wound colonization by nasal mupirocinA M D Kooistra-Smid, E van Zanten, A Ott, et al.
Journal of Clinical Immunology|May 28, 2004
T cells recognize multiple GAD65 and proinsulin epitopes in human type 1 diabetes, suggesting determinant spreadingPatrick A Ott, Marcus T Dittrich, Bernhard A Herzog, et al.
Frontiers in Oncology|April 16, 2019
Palliative Radiation Therapy for Vertebral Metastases and Metastatic Cord Compression in Patients Treated With Anti-PD-1 TherapyMuhammad Mohsin Fareed, Luke R G Pike, Andrew Bang, et al.
Molecular Pharmaceutics|November 4, 2014
In silico prediction of pharmaceutical degradation pathways: a benchmarking studyMark H Kleinman, Steven W Baertschi, Karen M Alsante, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 25, 2019
Developing real-world comparators for clinical trials in chemotherapy-refractory patients with gastric cancer or gastroesophageal junction cancerIan Chau, Dung T Le, Patrick A Ott, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|November 4, 2019
Correction to: Developing real-world comparators for clinical trials in chemotherapy-refractory patients with gastric cancer or gastroesophageal junction cancerIan Chau, Dung T Le, Patrick A Ott, et al.
Cancer Immunology, Immunotherapy : CII|February 13, 2024
INDUCE-2: A Phase I/II, open-label, two-part study of feladilimab in combination with tremelimumab in patients with advanced solid tumorsJohn F Hilton, Patrick A Ott, Aaron R Hansen, et al.
Journal of Autoimmunity|July 9, 2004
Increased in vivo frequency of IA-2 peptide-reactive IFNgamma+/IL-4- T cells in type 1 diabetic subjectsBernhard A Herzog, Patrick A Ott, Marcus T Dittrich, et al.
Pageof 67